Utility of Pap Smear Screening for Prevention of Cervical Cancer-A 3yrs Study from Rural Tripura-A Northeastern State of India

Debashis Saha, Suman Ghosh, S. Nath, Habibul Islam
{"title":"Utility of Pap Smear Screening for Prevention of Cervical Cancer-A 3yrs Study from Rural Tripura-A Northeastern State of India","authors":"Debashis Saha, Suman Ghosh, S. Nath, Habibul Islam","doi":"10.19056/IJMDSJSSMES/2017/V6I2/149896","DOIUrl":null,"url":null,"abstract":"Background: Cancer cervix is a leading cause of mortality and morbidity among women worldwide. According to National Cancer Registry Program of India, cancers of cervix and breast are leading malignancies in Indian women. The morbidity and mortality could be significantly reduced with an active cervical smear screening programme. Objective: The study was done to evaluate the knowledge and attitudes of women about cervical smear testing, to establish a cervical smear screening program and to evaluate the cervical cytological abnormalities. It was done to determine the applicability, limitations and utility of this screening in a district hospital. Materials and Methods: A total of 287 married women were included in our study. Knowledge about Pap smear testing was determined through printed questionnaires. Pap smear screening was performed on every woman in our study group. Detailed clinical data and cytology reports were noted in a proforma. Results: About 92% women of our study group had never heard or undergone Pap smear screening before. Maximum number of patients was in 4th decade. Of the 287 smears, 276(96.16%) were adequate. Normal smear were 78(27.18%), inflammatory 168(58.54%), whereas epithelial cell abnormalities were seen in 26(9.05%) cases. The 26 abnormal cases comprised of 17(5.92%) cases with ASCUS, 5(1.74%) cases of LSIL, 1(0.35%) cases of HSIL, 3(1.04%) cases of squamous cell carcinoma. Conclusions: Epithelial cell abnormality in our study group was less than Western countries. There is poor knowledge about Pap smear screening. Pap smear study can be easily done through a chain built between the primary health care unit and district hospital and laboratory.","PeriodicalId":14010,"journal":{"name":"International Journal of Medical and Dental Sciences","volume":"40 1","pages":"1456-1461"},"PeriodicalIF":0.0000,"publicationDate":"2017-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"10","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Medical and Dental Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19056/IJMDSJSSMES/2017/V6I2/149896","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 10

Abstract

Background: Cancer cervix is a leading cause of mortality and morbidity among women worldwide. According to National Cancer Registry Program of India, cancers of cervix and breast are leading malignancies in Indian women. The morbidity and mortality could be significantly reduced with an active cervical smear screening programme. Objective: The study was done to evaluate the knowledge and attitudes of women about cervical smear testing, to establish a cervical smear screening program and to evaluate the cervical cytological abnormalities. It was done to determine the applicability, limitations and utility of this screening in a district hospital. Materials and Methods: A total of 287 married women were included in our study. Knowledge about Pap smear testing was determined through printed questionnaires. Pap smear screening was performed on every woman in our study group. Detailed clinical data and cytology reports were noted in a proforma. Results: About 92% women of our study group had never heard or undergone Pap smear screening before. Maximum number of patients was in 4th decade. Of the 287 smears, 276(96.16%) were adequate. Normal smear were 78(27.18%), inflammatory 168(58.54%), whereas epithelial cell abnormalities were seen in 26(9.05%) cases. The 26 abnormal cases comprised of 17(5.92%) cases with ASCUS, 5(1.74%) cases of LSIL, 1(0.35%) cases of HSIL, 3(1.04%) cases of squamous cell carcinoma. Conclusions: Epithelial cell abnormality in our study group was less than Western countries. There is poor knowledge about Pap smear screening. Pap smear study can be easily done through a chain built between the primary health care unit and district hospital and laboratory.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
巴氏涂片筛查预防宫颈癌的效用——印度东北部特里普拉邦农村3年研究
背景:宫颈癌是全世界妇女死亡和发病的主要原因。根据印度国家癌症登记计划,宫颈癌和乳腺癌是印度妇女的主要恶性肿瘤。积极进行子宫颈细胞涂片检查可大大降低发病率和死亡率。目的:了解妇女对子宫颈涂片检查的知识和态度,建立子宫颈涂片筛查方案,评价子宫颈细胞学异常情况。目的是确定该筛查方法在某地区医院的适用性、局限性和实用性。材料与方法:本研究共纳入287名已婚妇女。对子宫颈抹片检查的了解是通过印刷的问卷来确定的。我们研究组的每位女性都进行了子宫颈抹片检查。详细的临床资料和细胞学报告以形式记录。结果:我们研究组中约92%的女性从未听说过或接受过子宫颈抹片检查。患者人数最多的是在第40年。287例涂片中,276例(96.16%)合格。涂片正常78例(27.18%),炎性168例(58.54%),上皮细胞异常26例(9.05%)。26例异常病例中,ASCUS 17例(5.92%),LSIL 5例(1.74%),HSIL 1例(0.35%),鳞状细胞癌3例(1.04%)。结论:我国研究组上皮细胞异常发生率低于西方国家。人们对子宫颈抹片检查知之甚少。通过在初级卫生保健单位和地区医院和实验室之间建立的链条,可以很容易地进行子宫颈抹片检查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Topical Application of Citrus limon Peel Essential Oil Increased Pro-Inflammatory Cytokines Expression on Type IV Hypersensitivity Reaction Role of Intraoral Scanners in Pediatric Dentistry The Wider Meaning of Addiction Antibacterial Power of Nano Brown Anchovy (Stolephorus insularis) Against Mixed Bacteria in Deep Dentin Caries Scientific Integrity-Overcoming Challenges in Medical Research and Publication
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1